CD40 and neoplasm: In this study, we hypothesized that oncolytic adenovirus could lyse tumor cells to release tumor specific antigens and inhibit TGF-β signaling to remodeling tumor microenvironment, and then activated immune cells by CD40-CD40L signaling.